Virtual Reality for Autism
(SoCaVR Trial)
Trial Summary
What is the purpose of this trial?
The goal of this randomized clinical trial is to compare and learn about Virtual Reality (VR) in children with autism/Autistic children. The main question it aims to answer is: • Does the Floreo VR clinical product show clinical improvement in autism symptoms? Participants will engage the VR product for twice a week for twelve weeks. They will be randomized to either the Floreo Clinical Product or a VR Control group experience. Researchers will compare the two groups to see if there is an effect on learning specific skills and behaviors.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Floreo VR for autism?
Is virtual reality safe for people with autism?
How is the Floreo VR treatment different from other autism treatments?
Floreo VR is unique because it uses virtual reality to create interactive, three-dimensional simulations of real-world settings, helping individuals with autism develop social and interaction skills in a safe and controlled environment. This approach is different from traditional therapies as it provides an immersive experience that can be both engaging and effective for learning practical life skills.12458
Research Team
Suzanne Goh, MD
Principal Investigator
Cortica
Eligibility Criteria
This trial is for children with autism, including those diagnosed with Autism Spectrum Disorder or Social Communication Disorder. They'll use VR technology twice a week for twelve weeks to see if it helps improve their social skills.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage with the VR product twice a week for twelve weeks, randomized to either the Floreo Clinical Product or a VR Control group experience
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 16, 20, and 24 weeks
VR Control Crossover
Participants who opt in will run the 12 week Floreo VR program
Treatment Details
Interventions
- Floreo VR
- VR Control
- VR Control Crossover
Floreo VR is already approved in United States, European Union for the following indications:
- Autism Spectrum Disorder (ASD) therapy
- Social skills training
- Communication skills training
- Autism Spectrum Disorder (ASD) therapy
- Social skills training
- Communication skills training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Floreo, Inc.
Lead Sponsor